In patients with type 1 diabetes (T1D), sodium-glucose cotransporter 2 (SGLT2) inhibitors plus glucagon receptor antagonists (GRAs) may improve glycemic control, reduce insulin use, and mitigate ...
Use of SGLT2 inhibitors rather than GLP-1 receptor agonists is associated with lower risk of progression to kidney replacement therapy among patients with type 2 diabetes and CKD. The risk of ...
BOSTON -- Sodium-glucose cotransporter-2 (SGLT2) inhibitors were linked to long-term reductions in mortality risk among patients with pulmonary arterial hypertension (PAH), according to an ...
Recent advances in type 2 diabetes treatment are reshaping care for patients with chronic kidney disease (CKD). SGLT2 inhibitors and GLP-1 receptor agonists now have FDA approval for slowing kidney ...
LAKEWOOD, CO, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- The American Animal Hospital Association (AAHA) today ...
UBM Medica US announces that Endocrinology Network, a leading online community for endocrinologists and other clinicians who treat patients with T2DM offers comprehensive and up-to-date coverage of ...
SGLT2 inhibitor use was associated with lower risks for dementia and cardiovascular events among patients with diabetes and atrial fibrillation. Sodium-glucose cotransporter-2 (SGLT2) inhibitor use is ...
Compared with DPP-4 inhibitors, SGLT-2 inhibitors were linked to a lower risk for incidental Parkinson disease among older adults with type 2 diabetes. Use of sodium-glucose cotransporter-2 (SGLT-2) ...
Everyday Health on MSN
A guide to medications for type 2 diabetes and chronic kidney disease
Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...
As a class, sodium–glucose transporter 2 inhibitors are novel drugs initially developed for glycemic control in patients with type 2 diabetes. [Cowie MR, et al. Nat Rev Cardiol. 2020;1a] Their primary ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nihar R. Desai, MD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results